Lastly, pharmacological modulation of CD8+ T cell metabolism by pre-treating antigen-specific CD8+ T cells with the glucose analogue 2-Deoxyglucose (2-DG), which inhibits glycolysis, improved CD8+ T cell function upon chronic viral infection. The gene discussed is CD8A; the disease is viral infectious disease.